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2 Abstract 
Osteopontin (OPN) is a member of the small integrin binding ligand N-linked 
glycoprotein (SIBLING) family of proteins. The molecular structure of OPN contains 
unique structural motifs, which mediate cell-matrix and cell–cell signaling through the 
αvβ integrin family and CD44 receptors in a variety of normal and pathologic processes. 
Avian fibroblasts simultaneously transformed by v-myc and v-mil(raf) display 
significantly elevated levels of the transcription factor complex AP-1 which subsequently 
leads to upregulation of the osteopontin (OPN) encoding gene (OPN). Elevated OPN 
expression is commonly observed in tumor cells where it plays crucial roles in 
remodeling processes such as inflammation, bone resorption and tumor progression.  
OPN belongs to the class of intrinsically unfolded proteins (IUP) with no apparent 
ordered tertiary structure detectable. Intrinsically unfolded proteins have challenged the 
structure–function paradigm in current biology, since they are now recognized to play 
essential roles in transcription, translation and signal transduction pathways. The absence 
of defined structure allows disordered regions of proteins to acquire a high degree of 
plasticity but also represents an easy target for misfolding, often leading to disease. 
NMR is uniquely suited to elucidate the structural and dynamic features of these unfolded 
states. A combination of 15N-relaxation time measurements, pulsed-field gradient (PFG) 
diffusion measurements, residual dipolar couplings and paramagnetic relaxation 
enhancement experiments were applied to characterize the dynamic properties of OPN. 
This work will address the connection between the molecular structure of Osteopontin 
and its versatile physiological functions.  
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3 Zusammenfassung 
Osteopontin (OPN) ist ein Mitglied aus der Familie der small integrin binding ligand N-
linked glycoproteins (SIBLINGs). Seine molekulare Struktur beinhaltet Motive, die für 
Zell-Zell und Zell-Matrix Signaling via der αvβ-Integrin- oder CD44 Rezeptoren in 
normalen sowie pathologischen Prozessen notwendig sind. 
v-myc and v-mil(raf) co-transformierte Hühner Fibroblasten besitzen eine erhöhte 
Konzentration des Transkriptionsfaktors AP-1, welcher zu einer erhöhten Expression des 
für OPN kodierenden Gens OPN führt. Eine erhöhte OPN Expression ist häufig in 
Tumorzellen zu beobachten, wo das Protein an einer Reihe von Prozessen wie 
Remodeling, Inflammation, Knochen Resorption und Tumorwachstum. 
OPN ist ein sogenanntes intrinsically unfolded protein (IUP) mit keiner definierten 
Tertiärstruktur. IUPs stellen das gängige Struktur-Funktions Paradigma der Biologie in 
Frage. Trotz des Fehlens einer definierten Struktur sind sie an wichtigen Prozessen wie 
Transkriptions, Translations und Signaltransduktionsprozessen beteiligt. Seine 
konformationelle Flexibilität macht es jedoch auch zum Ziel von Misfolding was häufig 
zu Krankheiten führt. 
NMR eignet sich hervorragend dazu, die Dynamik und Struktur solcher ungefaltenen 
Proteine genauer unter die Lupe zu nehmen. Eine Kombination aus 15N-
Relaxationsmessungen, pulsed-field gradient (PFG) diffusion measurements, residual 
dipolar couplings (RDCs) und paramagnetic relaxation enhancement (PRE) 
Experimenten wurde verwendet, um den dynamischen Charakter von OPN genauer zu 
untersuchen. Diese Arbeit versucht, die molekulare Struktur von OPN mit seinen 
vielschichtigen physiologischen Aufgaben in Verbindung zu bringen.  
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4 Introduction 
4.1 The SIBLING family 
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs) are a family of five 
integrin-binding glycophosphoproteins comprising osteopontin (OPN), bone sialoprotein 
(BSP), dentin matrix protein 1 (DMP1), dentin sialophosphoprotein (DSPP) and matrix 
extracellular phosphoglycoprotein (MEPE). 
Each of the SIBLING genes map to human chromosome 4 and all of the SIBLING 
proteins contain the integrin binding motif, Arg–Gly–Asp (RGD) [1]. SIBLING 
expression was first evidenced in mineralized tissue including bone and teeth. Recent 
studies have demonstrated that SIBLINGs localize to neoplastic tissues and function in 
mediating metastasis.  
All of the SIBLING proteins are extended and flexible in solution, a property shared by 
numerous proteins with multiple binding partners. Consistent with that observation, 
SIBLINGs bind to a number of different protein families, including integrins (through 
both RGD and non-RGD motifs), other cell-surface proteins (e.g. CD44), complement 
factor H (CFH) and members of the matrix metalloproteinase (MMP) family. 
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Figure 1: SIBLINGs mediate cell–matrix interactions and cellular signalling. 
These interactions enable cell surface localization and release of MMPs and CFH by at 
least OPN, BSP and DMP1, thereby enabling their biological functions (e.g.: 
extracellular matrix degradation and evasion of complement-mediated lysis). Some 
members of the SIBLING family were discovered as abundant proteins trapped within 
the mineralized tissue of bone and dentin [2],[3]. In the early years of research, each of 
these proteins was thought to be both skeletal tissue-specific and to have a role in 
nucleating hydroxyapatite crystals within mesenchymal tissues. [4] From the 1990s, 
various combinations of SIBLING proteins were discovered to be significantly 
upregulated in a number of epithelial tumors known to metastasize to bone [5]. 
SIBLINGs are secreted proteins that are localized through interactions with receptors 
either on their own cell surface, enabling autocrine activities, or by diffusing short 
distances to surrounding cells where they may function in paracrine signaling. SIBLINGs 
propagate biological signals by initiating integrin signaling and by recruiting other 
proteins to the cell surface. 
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4.2 SIBLINGs and tumor progression 
Tumor progression involves a series of events that grants transformed cells a higher 
survivability. These events start with neoplastic transformation and continue with the 
deactivation of proliferation blockades, growth restriction, physical barriers and host 
defence systems. Cancer cell survival is dependent on proliferation, interaction with the 
extracellular matrix to create space to grow, pathways for nutrient access and escape of 
the cells to a new environment. Successful progression also involves cellular responses 
and evasion of immune surveillance. 
4.2.1 Survival and proliferation 
At the primary site, cancer cells secrete high levels of small integrin-binding ligand, N-
linked glycoproteins (SIBLINGs), which favor their proliferation (osteopontin (OPN) and 
bone sialoprotein (BSP)) and survival (OPN, BSP and dentin matrix protein 1 (DMP1)). 
Cancer cells bind to SIBLINGs and their various proteolytic fragments through their 
integrin receptors by both RGD-dependent and RGD-independent interactions. OPN, and 
perhaps DMP1, can also interact with specific splice variants of CD44 that are expressed 
by cancer cells.	  
Osteopontin is the best-studied protein among the SIBLING family and the intracellular 
signaling pathways present in OPN modulation of cell proliferation and migration are 
well understood. The binding of OPN to CD44 promotes cell migration through kinase 
cascades involving phospholipase Cγ, protein kinase C, phosphatidylinositiol 3-kinase 
(PI3K) and Akt, a serine/threonine kinase that regulates cell cycle progression, growth 
factor-mediated survival and cell migration (Figure 2a). The binding of αvβ3 by OPN is 
associated with SRC kinase-mediated complex formation between αvβ3 and EGFR, 
which activates the mitogen-activated protein kinase (MAPK) pathway and results in the 
promotion of tumor growth (Figure 2b). The effects of SIBLINGs other than BSP and 
OPN on cell proliferation have not been investigated yet. 
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Figure 2: Survival / Resistance to Apoptosis and Proliferation  
4.2.2 Invasion and ECM degradation 
Cancer cells exhibit a high motility in combination with increased expression of proteases 
that are able to degrade the ECM thus providing them with a high invasive capability 
[6],[7]. Both OPN and BSP are expressed at increased levels by several cancers 
contributing to their invasive potential. 
Invasive cells can degrade the extracellular matrix through at least two pathways of 
controlled proteolysis: the urokinase-type plasminogen activator (uPA) pathway and the 
MMP (matrix metalloproteainase) pathway (Figure 3).  
Several studies with recombinant OPN show that this SIBLING member significantly 
increases in vitro invasiveness: 
In a metastatic murine mammary cancer cell lines model, the binding of OPN to integrin 
receptors induces MMP2 and uPA expression through integrin linked kinase (ILK)-
dependent AP1 activity [8]. It has recently been shown that OPN induces αvβ3 integrin-
mediated AP1 activity and uPA secretion by activating SRC–EGFR–ERK (extracellular 
signal-regulated kinase) signaling pathways and further demonstrates a functional 
molecular link between OPN-induced integrin- and SRC-dependent EGFR 
phosphorylation and ERK- and AP1-mediated uPA secretion, and all of these ultimately 
control the motility of breast cancer cells [9]. Potential mechanisms for SIBLING-
enhanced matrix degradation have been described. BSP and OPN induce the activation of 
MMP2 in GCT23 giant cell tumour cells [10]. OPN binding to αvβ3 is associated with 
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PI3Kmediated NFκB activation and nuclear factor-inducing kinase (NIK, also known as 
mitogen-activated protein kinase kinase kinase 14 (MAP3K14)) activation of AP1 and 
NFκB, which stimulate uPA-dependent MMP9 activation [11]. Thus, at least two 
SIBLINGs can induce MMP expression. BSP, DMP1 and OPN bind to and modulate the 
activity of MMP2, MMP9 and MMP3, respectively [12]. SIBLING-mediated MMP 
activation includes both making the proMMPs enzymatically active to some degree and 
reactivating MMPs that are inhibited by tissue inhibitors of MMP (TIMPs) [12]. Another 
mechanism might involve enzymatic processing of SIBLINGs that alters invasion and 
migration properties. For example, increased hepatocellular carcinoma cell invasion was 
attributed to OPN peptides cleaved by MMP9 and thrombin [13]. 
 
Figure 3: Tumor invasion of surrounding tissue 
4.2.3 Metastasis 
The process of metastasis is very complex and is split into several stages: The 
proliferation of malignant cells at the primary site is followed by spreading, to invade 
surrounding capillary or lymphatic vessels. Tumor cells are able to resist immunological 
attacks and eventually gain access to secondary sites where they proliferate to form a new 
tumor [14]. Throughout this multi-step progression, cancer cells interact with ECM-
proteins and various types of cells. Multifunctional ECM-proteins such as the SIBLINGs 
are anticipated to have key roles in metastasis as they affect adhesion, migration and 
matrix degradation (Figure 1).  
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OPN was the first member of the SIBLING family found to confer a metastatic 
phenotype on cells that originally formed benign tumors [15]. Since this initial 
observation, several studies conducted with various types of cancer from human tissue 
report that tumors that are likely to progress to more advanced stages exhibit de novo or 
increased expression of SIBLINGs. In particular, the correlations between high levels of 
OPN expression in tumor cells and its pro-metastatic role have been observed. So far, 
high expression of SIBLINGs is associated with osteotropic cancers including breast 
[16], prostate [17] and lung [18] as well as multiple myeloma [19]. 
4.2.4 Inflammation and complement evasion 
A very interesting feature of SIBLING proteins is their function as part of the immune 
system. OPN is secreted by activated macrophages, leukocytes and activated T 
lymphocytes [20-22] and is also a chemotactic cytokine for macrophages [23], dendritic 
cells [24] and neutrophils [25]. It is possible that OPN expression by tumors actually 
promotes inflammation induced cancer growth and progression through, for example, the 
promotion of macrophage and neutrophil infiltration. Tumor cells that secrete OPN might 
be propagating chronic inflammation, which can accelerate transformation and tumor 
progression.	  
The complement system is yet another part of the immune system SIBLING proteins are 
involved in. The complement system is composed of about 26 proteins that combine with 
antibodies and/or cell surface molecules as part of the humoral response. The 
complement cascade has a role in inflammation, opsonization, viral neutralization, cell 
lysis and localization of antigen [26]. Nearly all cells are subject to constant low levels of 
complement attack, but only cells that do not express the correct cell surface proteins, 
thereby inactivating the early steps of the cascade, are killed. CFH is a major negative 
regulatory factor that quenches complement- mediated lysis. Cells that become 
transformed may escape the complement system during their transit through the patient’s 
circulation by upregulating genes that help to control this aspect of immune surveillance. 
As such, the expression of SIBLINGs (specifically OPN, DMP1 and BSP) by tumor cells 
might provide such a selective advantage for survival by mediating the binding of CFH to 
the cell surface through integrins and/or CD44. The activated CFH then inhibits the 
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formation of the membrane attack complex and subsequent cell lysis (Figure 4). In vitro 
experiments have demonstrated that these three SIBLINGs can protect murine and human 
cancer cell lines from attack by complement [27-29]. 
 
Figure 4: Complement evasion 
4.2.5 Angiogenesis 
Angiogenesis promotes tumor growth as well as metastatic spread through a complex 
interplay of positive and negative mediators of extracellular matrix degradation and 
endothelial cell and vasculature recruitment. There is evidence that αvβ3 is a key 
angiogenesis-associated receptor that is significantly upregulated on the surface of 
activated endothelial cells [30]. OPN and BSP have been shown to act as pro-angiogenic 
factors and, based on their RGD motifs, it is likely that the other SIBLINGs may also 
interact with αvβ3 integrin and influence the behavior of endothelial cells. OPN 
contributes to the genesis of new capillaries infiltrating the cancer lesion in several in 
vivo models [31],[32]. The integrin αvβ3 mediates the migration of activated endothelial 
cells during vessel formation. SIBLINGs, as ligands for αvβ3 through the RGD sequence, 
may stimulate endothelial cell migration. It is also possible that SIBLING modulation of 
protease activity (uPA or MMP) generates bioactive fragments of extracellular matrix 
components responsible for angiogenesis. Experimental evidence suggests that 
antagonizing the ligation of SIBLINGs to integrins is a promising approach for the 
inhibition of angiogenesis and associated tumor growth. For example, blocking the 
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interaction between OPN and αvβ3 inhibits angiogenesis and stops lung cancer growth in 
mice [31]. The αvβ3 integrin was shown to be important for OPN-mediated NFκB 
induction and survival, as adding a neutralizing anti-β3 integrin antibody blocked NFκB 
activity and induced endothelial cell death when cells were plated on OPN [33]. A recent 
study demonstrates that OPN triggers vascular endothelial growth factor-dependent 
breast tumor growth and angiogenesis by autocrine and paracrine mechanisms [34]. Thus, 
it is possible that, through their interaction with αvβ3, the SIBLINGs may also cooperate 
with molecules that have important biological functions during angiogenesis and tumoral 
growth processes, including MMPs, growth factors and their receptors. 
 
Figure 5: Angiogeesis, Blood Transport and Metastasis 
4.2.6 Microcalcification 
All SIBLINGs are expressed by bones and teeth. Outside of the skeletal system, 
pathological dystrophic calcification associated with the upregulation of OPN and/or BSP 
has been observed. Notable among these are atherosclerotic vascular plaques and kidney 
stones [35]. Because of their earlier association with mineralization in bone, the 
expression of BSP and OPN has been studied in cancers such as breast and thyroid 
carcinomas, in which ectopic calcification occurs [36],[37]. Tumors from the primary 
sites of bone-seeking cancers frequently contain foci in the form of hydroxyapatite (HA) 
microcalcifications.  
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OPN is capable of both inhibiting and stabilizing the formation and growth of 
hydroxyapatite and other biominerals. The interaction of OPN with HA is determined by 
the extent of protein phosphorylation and that this interaction regulates the mineralization 
process. [38] For example recombinant, nonphosphorylated OPN and chemically 
dephosphorylated OPN, has no effect on HA formation or growth. In contrast, highly 
phosphorylated milk OPN promoted HA formation. A feature of many of the anionic 
extracellular matrix proteins that regulate initial formation and growth of HA crystals and 
other biominerals [39][40] is their ability at low concentrations to stabilize the first 
formed “critical” HA nuclei facilitating initial mineral and, at higher concentrations, to 
bind to crystals limiting their growth and proliferation. 
4.3 Molecular structure of OPN 
In this work, a truncated 220 amino acid long OPN version from quail was used for all 
experiments. From now on it will be referred to as OPN200 in all the subsequent data. 
OPN exhibits a high degree of sequence homology among species. (Figure 6: Multiple 
Sequence Alignment of OPN220 with human-OPN and native quail-OPN. Conserved 
regions are highlighted in blue. Important binding motifs are boxed in red.) 
 
Figure 6: Multiple Sequence Alignment of OPN220 with human-OPN and native quail-OPN. 
Conserved regions are highlighted in blue. Important binding motifs are boxed in red. 
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OPN is rich in aspartate, glutamate and serine residues and contains functional domains 
for extra-cellular matrix adhesion. (Figure 7: Schematic representation of the domain 
structure of OPN220.Figure 7) It interacts with a variety of integrins, including αvβ3, 
αvβ5, αvβ1, α4β1, α8β1 and α9β1, as well as CD44. 
 
Figure 7: Schematic representation of the domain structure of OPN220. 
Integrin mediated cell adhesion and migration are stimulated in assays in which full-
length OPN is immobilized on tissue culture dishes. Thrombin cleavage of the protease 
hypersensitive RSK (RAK in quail) sequence separates the integrin- and CD44-binding 
domains, which in some cases promotes adhesion over migration. For example, the 
thrombin-generated amino-terminal OPN fragment binds to αvβ3 and αvβ5 integrins 
(through the RGD motif [41]) or to α9β1 and α4β1 integrins (through the cryptic 
SVVYGLR sequence which is only partly conserved in quail [42]) and promotes cell 
adhesion. The carboxy-terminal fragment binds to CD44 and promotes invasion, 
tumorigenesis and the formation of foci [43]. 
OPN contains a polyaspartic acid sequence (D99-D105 in OPN220) and sites of Ser/Thr 
phosphorylation, of which half are highly conserved. In non-recombinant proteins, these 
residues are postulated to mediate OPN binding to hydroxyapatite [44]. Human OPN also 
contains transglutaminase-reactive glutamine residues (Q34 and Q36) not found in quail-
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OPN that allow it to be cross-linked by transglutaminase enzymes. This cross-linking 
results in the formation of OPN polymers, which also bind to HA [45][46][47]. 
4.4 The advantage of being intrinsically unstructured 
In the recent years, a large number of papers on proteins denoted as ‘natively unfolded’ 
or ‘intrinsically unstructured/disordered’ have appeared. The term intrinsically unfolded 
can be misleading, because rather than having no structure, these proteins sample a lot of 
conformations with no distinct energy minimum, which is in stark contrast to globular 
proteins. Unstructured proteins have no enzymatic activity, as a proper organization of 
the active site residues requires a well-structured fold they cannot provide, but exhibit 
order at the level of primary and secondary structure that correlates with their functions. 
The lack of a stable fold and the exhibition of a rather extended conformation provide 
these proteins with a high intramolecular flexibility. 
IUPs differ significantly from average genomically encoded proteins in terms of size and 
amino acid composition. (Figure 8: Amino Acid Composition of OPN220) 
 
 
  
Amino acid frequencies for quail OPN220.  
The high abundance of proline and charged 
amino acids as well as the lack of cysteins 
is a shared characteristic among IUPs. 
Total number of negatively charged 
residues (Asp + Glu): 53 
Total number of positively charged residues 
(Arg + Lys): 21 
Figure 8: Amino Acid Composition of OPN220 
number of 
residues 
within OPN 
frequencies of 
residues 
within OPN 
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A low mean hydrophobicity and high net charge which are associated with the disordered 
state [48][49], preclude the formation of a hydrophobic cluster and promote an extended 
conformation by electrostatic repulsion. The lack of cysteine fits into this picture, as in 
globular proteins this amino acid is often found in active sites or stabilizing disulfide 
bonds that are not required in IUPs. High proline content is also linked with the lack of 
structure. Proline disfavors a stable tertiary structure but has a strong preference for an 
extended conformation in the form of polyproline II helices. Furthermore, proline is often 
involved in protein–protein contacts [50], supporting the high abundance of this amino 
acid in IUPs, which heavily rely on target recognition. 
Another unique functional feature of IUPs is that their open structure is largely preserved 
when they complex with their target, resulting in a large binding surface and multiple 
contact points for a protein of the given size. For effectors, it provides specificity because 
of interaction with distant regions on the target, as can be seen with the X-ray structure of 
the cyclin-dependent-kinase inhibitor p27Kip1 bound to the cyclin A–cyclin dependent 
kinase 2 (Cdk2) complex (Figure 9). 
 
Figure 9: Cyclin-dependent-kinase inhibitor p27Kip1 bound to the cyclin A–cyclin dependent kinase 
2 (Cdk2) complex 
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The high plasticity of IUP’s allows them to adopt different structures upon different 
stimuli or with different partners, which enables their versatile interaction with various 
targets. Such is exactly the case for the SIBLING proteins, which can interact with 
integrins, CD44 and complement factor H.  The lack of a stable tertiary fold and the high 
plasticity goes in hand with a high degree of intramolecular dynamics compared to stably 
folded proteins, a feature of OPN which was of particular interest to me. 
NMR is uniquely suited to elucidate these structural and dynamic features. A 
combination of NMR experiments including 15N-relaxation time measurements, pulsed-
field gradient (PFG) diffusion measurements, residual dipolar couplings and 
paramagnetic relaxation enhancement experiments in combination with SAXS and CD 
were applied to characterize global and dynamic properties of OPN.  
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5 Results 
Osteopontin is a very interesting protein by all means. Structure determination by 
conventional NMR experiments is not possible, due to the unstructured nature of all of 
the SIBLING members. Nevertheless it is possible to get some insights on the dynamic 
properties of intrinsically unstructured proteins. 
During the past decade numerous NMR techniques have been developed for elucidating 
the unfolded states of proteins in atomic detail [51]. 15N-relaxation time measurements 
and paramagnetic relaxation enhancement (PRE) from site-directed spin labeling allowed 
the detection of native-like contacts and hydrophobic clusters in proteins [52][53]. In 
addition, measurement of residual dipolar couplings (RDCs) in a weakly aligned protein 
provides long-range orientational information and may reveal residual native-like 
topology in the unfolded states of proteins [54][55]. 
The first half of the results part will deal with a detailed analysis of global (size and 
composition of secondary structure elements) as well as dynamic properties (T1, T2, 
heteronucular NOE, RDC’s, PRE’s) of osteopontin and the corresponding NMR 
experiments this data was extracted with. 
The second part will be concentrated on another interesting feature of IUPs. They are 
almost completely devoid of a folded structure, therefore exhibiting a very high binding 
plasticity. The fact that Osteopontin is known to bind a number of ligands including 
integrins, CD44 and MMPs made us curious. Hence we decided to make use of Robert 
Konrats Meta-Structure Algorithm to search for putative ligands for osteopontin. 
The Meta-Structure concept was developed by Robert Konrat with the aim to extract 
information about protein structure and function out of the primary sequence of a protein 
without the help of 3D structural information, which often, even at high resolutions, is 
insufficient to predict protein function or functional sites. Individual residues are treated 
as tightly interacting chemical entities and their mutual interdependences can be 
quantified using parameters borrowed from network theory. Meta-structure analysis from 
the primary sequence of a protein gives information about the compactness of a protein 
(whether proteins are highly structured, unstructured or partially folded). It can be used 
for the search of protein fold topology similarities (meta-structure homologues), which 
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are not necessarily visible in the primary sequence of proteins. Furthermore, it is able to 
predict protein interaction and ligand binding sites [56]. 
5.1 Secondary Chemical Shifts 
The differences between observed chemical shifts of nuclei spin types and their random 
coil values assigned in unfolded conformations serve as feasible tool for evaluating the 
residual preferences for protein secondary structure. Generally, backbone 1HN, 15N, 13Cα, 
and side-chain 13Cβ chemical shifts were used, using a set of established corrections 
factors. 
 
Figure 10: OPN220  13Cα chemical shifts 
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Figure 11: OPN220 13Cβ  chemical shifts 
 
Figure 10 and Figure 11 represent the sequence corrected secondary 13Cα, and 13Cβ 
chemical shifts for OPN. In α-helices, 13Cα appear to be shifted downfield relative to their 
random coil values, whereas 13Cβ are shifted upfield, so the effect of both nuclei spins are 
opposite in sign. In β-strands the converse applies. Overall, the main parts of the residues 
display chemical shifts values typically for random coils. However, for some residues 
small secondary shifts indicating a slight weighting towards α-helical conformation are 
apparent (for example: Leu58 to Leu68 and the core region from 130-150).  
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The region 116-131 displays harbours a large number of proline residues. This feature 
combined with the presence of many residues with comparably large negative secondary 
chemical shifts hints to a tendency for formation of a polyproline helix in this region.  
Residues 81, 184, 196 also display negative secondary chemical shift values, most 
probably due to the bordering prolines at these locations. 
5.2 Relaxation Parameters of OPN 
Measurement of NMR relaxation rates provides a window on protein dynamics over a 
broad range of time scales.  The longitudinal 15N-T1 values, transverse 15N-T2 values, and 
heteronuclear steady state NOE 15N{1HN} values are sensitive to dynamics on the pico-
second to nanosecond time scale, whereas 15N-T2 can also be effected by conformational 
or chemical exchange processes on the millisecond to microsecond time scale. Despite 
the rather small chemical shift dispersion of osteopontin in the HQSC spectra, in total for 
122 out of 183 assigned non-proline residues 15N relaxation data could be obtained at 298 
K and 600 MHz.  
 
Figure 12: OPN220 15N-T1 longitudinal relaxation times 
As indicated in Figure 12 the 15N-T1 measurements exhibit a largely monotonous and 
featureless distribution along the amino acid sequence, except for the C-terminal end, 
with an average value of around 600 ms.  
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Figure 13: OPN220 15N-T2 transversal relaxation times 
The residue plot of the experimental 15N-T2 values (Figure 13) shows several sequential 
variations ranging from 114 ms to 747 ms, which is in stark contrast to an expected 
parabolic form (with 15N-T2 minimum in the centre of the sequence) arising from a 
complete random structure without any structural preferences. Overall there is a good 
agreement between secondary chemical shifts (2nd structure formation) and motional 
restrictions probed by 15N T2 relaxation. Interestingly, the stretch Leu182-Trp183-Trp184 
also appears to be constrained presumably because of the spacious indol side chains.  
 
Figure 14: OPN220 heteronuclear 15N - NOE 
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The obtained steady state NOE 15N{1HN} (Figure 14) values in the center of the sequence 
are also found to be generally higher and strict positive in this area. Highest values (0.2 to 
0.37) are observable in the middle of the sequence and for Trp184 (0.35). Extensive 
patches of negative NOE values are apparent from residues Ala170 to Gly175, and more 
pronounced along a 9-residue stretch comprising residues Gly217 to Gly225, a motif 
build up by residues of small side chains (3 glycines, 2 alanines, 2 serines). In addition, 
these parts are displaying higher 15N-T2 values about 350 to 450 ms. The total average of 
15N-T2 is 280 ms. The intramolecular dynamics of osteopontin on a µs-to-ms time scale 
was investigated by state-of-the-art 15N-CPMG dispersion experiments (see Material and 
Methods). Numerical analysis of the relaxation rate R1ρ vs CPMG-frequency (νCPMG) 
profile, however, revealed for all the residues (resolved in the 2D 15N-1HN HSQC) flat 
dispersion profiles and thus indicating the lack of µs-to-ms time scale motions in OPN. 
5.3 Residual Dipolar Couplings for OPN unfolded states 
Another very useful tool for the characterization of IUPs involves the measurement of 
Residual Dipolar Couplings (RDCs). RDCs report on time-averaged conformations and 
can be used to understand both structure and dynamics of disordered proteins. RDCs are 
measured by weakly aligning a macromolecule in slightly anisotropic media, such as 
filamentous phages like PF1. The small degree of alignment resulting from the 
anisotropic environment leads to incomplete averaging of the dipolar couplings between 
magnetic nuclei close in space (typically directly attached). The magnitude of the RDC is 
dependent on the orientation of an internuclear vector such as 15N-1H	   relative to the 
alignment tensor of the protein as a whole. Therefore, valuable information about the 
relative orientation of individual bond vectors can be obtained.	  
The expected distribution of RDCs in unfolded proteins is globally followed in OPN 
(Figure 15), with negative couplings throughout the chain. 
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Figure 15: RDC-Profile of OPN220. 
Large negative RDCs are associated with locally more extended conformations. In more 
extended parts of the chain the NH interaction direction will tend to be perpendicular to 
the external field giving rise to negative RDC. Interestingly, some stretches within the 
polypeptide chain show positive RDC values. The occurrence of such sign inversion in 
unfolded chains has been interpreted as an increase in local propensity to form turns or α-
helical conformations.  
Positive RDC values in the regions 58-73 and 130-146 nicely correspond to data from 
secondary chemical shifts and meta-structure prediction, which also show α-helical 
propensities for these areas. Areas with negative RDC’s also compare with data from CD 
and secondary chemical shift, suggesting a large portion of the protein to occupy 
extended β-strand like conformation. 
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Figure 16: Isotropic and anisotropic doublets (aligned in PF1) of OPN220 
5.4 Probing of Long-Range Interactions in the Native State of 
OPN	  with	  PRE.  
While chemical shifts, and short and medium-range NOEs provide valuable insights into 
the secondary structural propensities of the polypeptide backbone in unfolded and partly 
folded proteins, it has generally proved difficult to observe long-range NOEs for 
unfolded or partly folded states. To circumvent this problem, site-specific nitroxide spin 
labeling can be utilized to probe transient long-range interactions in disordered proteins. 
In an effort to evaluate the contribution of local and non-local interactions on the residual 
structure of OPN, site-directed spin labeling (SDSL) of three different residues of OPN 
was performed. Because the primary sequence of OPN lacks cysteine, three different 
cysteine-containing mutants (S108C, S193C and S247C) were constructed to provide 
attachment points for the nitroxide radical 4-(2-Iodoacetamido)-TEMPO (IAAT) (Figure 
17). 
 28 
 
Figure 17: TEMPO attachment to cystein sidechains. 
The target residues for the cysteine substitution where targeted to regions of low 
compactness (Figure 18), predicted with Robert Konrats meta-structure algorithm. Within 
these regions, basepair triplets translating to a cysteine by introducing a single basepair 
substitution were chosen: 
 
Figure 18: Compactness of OPN220 
The interaction between a specifically attached paramagnetic nitroxide radical and nearby 
(< 25 Å) protons causes a broadening of their NMR signals because of an increase in 
transverse relaxation rate. This effect has an r-6 dependence on the electron–proton 
distance and thus allows the detection of long-range interactions in proteins. The peak 
intensity ratios between the two 15N-1H HSQC NMR spectra, i.e., in the presence and 
absence of the nitroxide radical (Iparam/Idiam), permit the estimation of distances between 
the spin label and the affected amide protons in the protein.  
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The effects of the nitroxide radical on the NMR spectra were very different for the two 
analyzed cysteine positions. Intensity ratios for the S108C (Figure 19) mutant showed a 
significant paramagnetic effect extending to residue 167. The same effect is present in the 
S193C mutant (Figure 20) suggesting a rather compact structure in the core region (126-
162) of OPN220. This region also comprises the helical patch from RDC data spanning 
the region from AS 130-146. This pattern is globally followed for S249C (Figure 21) 
although a larger scattering of intensity ratios was observed compared to the other two 
cystein mutants. 
 
Figure 19: PRE –Profile of TEMPO attached to C108-OPN220 mutant. 
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Figure 20: PRE –Profile of TEMPO attached to C193-OPN220 mutant. 
 
Figure 21: PRE –Profile of TEMPO attached to C249-OPN220 mutant. 
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5.5 Quantitative determination of secondary structure elements 
by Circular Dichroism (CD) 
CD is a convenient and widely used method for studying the conformations and 
conformational changes of proteins in solution. Mean ellipticity θ for OPN220 (Figure 
22) was measured at 20°C at 0.5 nm intervals from 180 – 260nm: 
 
Figure 22: Mean ellipticity θ  for OPN220 
Deconvolution of the OPN spectra was achieved by comparing it with 33 reference base 
spectra thereby calculating the contributions of the various components to the secondary 
structure: 
  
180-260 
nm 
185-260 
nm 
190-260 
nm 
195-260 
nm 
200-260 
nm 
205-260 
nm 
210-260 
nm 
Helix 15.00% 9.50% 9.70% 10.60% 11.00% 7.70% 7.90% 
Antiparallel 52.90% 55.40% 46.40% 35.00% 33.20% 33.20% 33.80% 
Parallel 2.80% 4.20% 4.60% 5.80% 5.90% 5.50% 5.50% 
Beta-Turn 16.70% 16.90% 16.50% 17.60% 17.50% 18.80% 19.30% 
Rndm. Coil 24.60% 25.40% 28.40% 33.50% 34.70% 34.90% 35.10% 
Total Sum 112.00% 111.40% 105.70% 102.60% 102.30% 100.10% 101.50% 
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The data obtained by CD strongly support data from RDC and secondary chemical shifts 
on OPN. Extended beta-strand like structures, mainly of antiparallel nature, show the 
highest contribtion to the secondary structure ensemble (30-50%). In addition, random 
coil contribution varies between 25-35%, supporting the idea of a largely unstructured 
conformation of Osteopontin. 
The total helical amount varies between 8-15% depending on the wavelength range. This 
is in very good agreement with RDC and secondary chemical shift data suggesting α-
helical propensities in the regions 58-73 and 130-146.  
CD thermal denaturation studies for Osteopontin were conducted at 218 nm (Figure 23) 
with no obvious melting behaviour detectable in the range from 20-60°C. This 
corroborates the lack of a stable tertiary structure of OPN. 
 
Figure 23: Thermal denaturation curve for OPN220 
 
5.6 Hydrodynamic radius measurement  
A pulsed field gradient (PFG) NMR diffusion measurement was conducted to get a rough 
idea on the diameter of the molecule in solution. The hydrodynamic radius (Rh) of OPN 
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was measured to 41.07 Å. According to the empirical relationship between the length of a 
polypeptide chain and its hydrodynamic radius [57], a globular 220 residues protein 
should have an Rh of 22,7 Å, whereas the same unfolded peptide chain should exhibit an 
Rh of 47.8 Å. The relatively large Rh of OPN (41.07 Å) in comparison to expected value 
for a globular form (22,7 Å) indicates that under these conditions OPN is mostly 
unfolded. Nevertheless, the lower Rh of OPN compared to the expected value for a 
completely unfolded chain (47.8 Å) suggests that OPN retains some local compactness in 
solution or samples conformations in which the polypeptide is more compact 
(presumably due to transient secondary elements as well as long-range residue contacts 
being formed).  
Independent experimental data for the hydrodynamic behaviour of OPN were provided 
by a small-angle X-Ray scattering analysis. The one-dimensional scattering curves were 
further treated using the program GIFT. The interaction of the proteins in solution was 
negligible since the concentration was low and any charge-contribution from ions were 
excluded by subtracting a buffer-only spectra from the protein-buffer spectra. The 
scattering was thus only related to the overall shape, the electron density and its 
distribution within the protein. The pair distance distribution function (PDDF) was 
obtained by Indirect Fourier Transformation (IFT). This function can be seen as a 
histogram of distances occurring in the protein. The shape of the PDDF can be evaluated 
in order to gain information about the structure of the protein. A Gaussian coil of a 
polymer has a linear increase of the PDDF at low distances. At higher distances the 
function shows a slow abatement. Figure 24 shows the PDDF extracted from the 
experimental scattering curve of OPN. 
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Figure 24: Pair Distance Distribution Function (PDDF) for Osteopontin (solid line) and Q83 (dashed 
line) 
The linear increase can clearly be observed in the PDDF of the protein. The decrease of 
the function is flatter than it would be expected for a Gaussian coil. This indicates that the 
structure of the protein is more elongated than a conventional Gaussian-coil. The 
maximum dimension of the protein can be read off of the PDDF and it is about 210 Å. 
Furthermore a shoulder in the function at about 15 Å can be observed. It is important to 
mention at this point that the scattering curve is a sum of the scattering, which is caused 
by all structures appearing in the measured volume during the measurement time. So the 
extracted PDDF contains contributions of all structures occurring in the sample. An 
explanation for the shoulder in the PDDF provides evidence for the fact that the protein 
exists in more than one structure. For comparison, Error! Reference source not found. 
also shows the PDDF curve of the stably folded lipocalin protein Q83. The strikingly 
different hydrodynamic behavior is clearly identified by the SAXS data. The average 
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radius of gyration of Q83 was determined to 21.3 Å. That is in very good agreement with 
the 3D structural data obtained by NMR spectroscopy. 
 
5.7 Ligand Interaction 
OPN was reported to bind Heparin by several articles although no experimental evidence 
was given. [58][59]. In order to provide more specific information about the binding site 
and the mode of binding we performed 15N-1H HSQC spectroscopy.  
  
Figure 25: Overlay of HSQC spectra of free OPN220 and when bound to Heparin 
Figure 25 shows an overlay of HSQC spectra of unligated OPN and when bound to 
Heparin. As can be seen from the figure there is evidence for specific interaction between 
OPN and Heparin. Although the majority of peaks were unchanged several residues 
experienced significant chemical shift changes upon heparin binding. Overall the 
magnitude of chemical shift changes were small, presumably because Heparin lacks 
aromatic ring systems and the fact that 15N-1H HSQC spectra report on the protein 
backbone and not on side-chains which are in direct contact with the ligand. Mapping the 
residues, which display frequency changes upon binding of Heparin on the protein 
backbone, clearly reveals a distinct binding side near the central Integrin-binding domain 
(residues 117 to 130 and 142 to 167). This is in striking contrast to existing domain 
analysis of OPN where the Heparin binding domain was located to the C-terminal 
domain (between Asp298-Ile305). Interestingly, Heparin-binding inhibited Thrombin-
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induced cleavage of OPN (data not shown) as the Heparin interaction site is overlapping 
with the RSK recognition sequence for thrombin cleavage. 
Additionally, calcium was also reported to bind to OPN, and the putative Calcium 
binding site was assigned to the residue stretch Asp216-Ser228. Again, 15N-1H HSQC 
spectroscopy was performed. However, no evidence of calcium binding could be found. 
The 15N-1H HSQC spectra were nearly unchanged even at a 1:30 molar access of calcium 
over OPN. This is in agreement with recently published data stressing the importance of 
phosphorylation for OPNs role in biomineralization processes [38]. Recombinant, and 
therefore nonphosphorylated OPN is not capable of binding calcium. 
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6 Discussion 
Structural and dynamic properties of Osteopontin (OPN) were investigated by means of 
multi-dimensional NMR spectroscopy and 15N relaxation parameters with supporting 
data derived from SAXS and Circular Dichroism (CD) measurements. Global parameters 
of the protein including compactness and composition of secondary structure elements 
are a good basis for further and more detailed investigations of a protein. Data from CD 
measurements already indicated a certain degree of secondary structure elements present 
in Osteopontin although the CD-data suggests that most of the protein seems to be in an 
extended β-strand like and/or random coil conformation. These findings are further 
supported by significant 13C secondary shifts observed for various segments along the 
polypeptide chain also hinting to the existence of local 2nd structure elements. 
The correlation between deviations from random coil chemical shift values and backbone 
dynamics provides convincing evidence for the existence of local structure elements 
involving residues that are located in reasonably well-ordered, hydrogen-bonded and 
motionally restricted parts of the polypeptide chain. Local motional restriction implies 
that residues located in these structurally preformed segments do not populate unfolded 
(random coil like) and rapidly interconverting α-helical conformations but rather exists in 
cooperatively folded local α-helices. Interestingly, these preformed and motionally 
restricted structural motifs comprise the biochemically established protein interaction 
motifs of OPN. No evidence for slower (ms-to-ms) time scale motions was found (based 
on 15N-CMPG dispersion measurements).  
The compactness of the protein is another interesting global parameter.  
A pulsed field gradient (PFG) NMR diffusion measurement yielded a hydrodynamic 
radius (Rh) for OPN of 41.07 Å. This result clearly differs from Rh220 expected for a 
globular (Rh220 ~23 Å) and for a completely unfolded protein (Rh220 ~48 Å). OPN is 
therefore neither a stably folded protein, nor completely unfolded with no apparent 
structure at all. Obviously OPN retains some local compactness in solution due to 
secondary elements present in the proteins structural ensemble. These findings were also 
supported by SAXS data recorded in Graz showing a maximal internal protein distance of 
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210 Å, although the majority of the protein ensemble is present in a more compact 
conformation. 
Information about compactness and secondary structure composition can be extracted out 
of the primary protein sequence using the meta-structure approach introduced by Robert 
Konrat. The meta-tructure approach allows sequence-based calculation of residue-
specific compactness and local 2nd structural features in proteins. [56] The local residue-
specific compactness value (Ci) is a quantitative parameter describing the structural 
complexity of an individual residue in the context of the 3D protein fold (e.g. inversely 
related to surface exposure). The combination of residue compactness and local 2nd 
structure as a function of residue position can be regarded as the protein’s meta-structure. 
Large values of Ci are found for residues located in stable parts of the protein and on 
average deeply buried in the interior of the structure. In contrast, small values are found 
for flexible loop regions and/or intrinsically unfolded segments of the polypeptide chain.  
A survey of PDB structures revealed an average compactness value of about 300 for a 
typically folded protein. The (protein specific) average compactness value can thus be 
used as a (coarse) benchmark value for screening for protein foldedness. The predicted 
average compactness values of OPN amounts to about 182. This is clearly below the 
average compactness value of 300 for all PDB entries. OPNs compactness is clearly 
below values observed for stably folded proteins, and thus supporting the notion that 
OPN is an intrinsically unstructured protein like the other members of the SIBLING 
family.  
Overall the NMR derived date is in good agreement with predicted meta-structure data. 
Increased compactness values were found for the region spanning residues 110 to 190 
aswell as 200 to 250. The region ranging from 110 to 190 shelters several binding sites 
for various integrins (residues 130-150). 15N-T2 data shows a motional restriction in 
exactly this region. 15N-NOE data further supports these findings showing generally 
higher and strictly positive 15N-NOE values in this region. The motional restriction hints 
to a preformed structure, although not highly populated, being formed in this region. This 
could be a necessary perquisite for OPN in order to interact with the various integrin 
isoforms. Interestingly, RDC values in this region are found to be positive, indicative of a 
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α-helical conformations, fully in agreement with secondary chemical shifts values in this 
region of the protein. It can be hypothezised that the interaction mode of integrins with 
osteopontin very likely requires OPN to adapt a defined secondary structure allowing it to 
interact with an integrin receptor.  
Another site of interest within osteopontin’s primary sequence is its putative CD44 
interaction site located n the C-terminal part of the protein (in proximity of residue 220). 
NOE values in this region are strictly negative and no motional restriction is apparent 
from 15N-T2 data in this region. The interaction mode for OPN-CD44 is very likely 
different from that of OPN-integrin. Since the structure of the OPN in this region doesn’t 
seem to be motionally restricted, an interaction mode similar to p27Kip1 bound to the 
cyclin A–cyclin dependent kinase 2 (Cdk2) complex (Figure 9) could be occurring. Since 
CD44 is a very large protein, OPN might retain it’s open conformation interacting with 
the CD44 via a large binding surface, thereby retaining most of its open conformation. 
This is a common mode of interaction for IUP’s, completely different from the second 
mode, requiring a preformed secondary structure to engage it’s binding partner as is the 
case for integrin binding.  
Taking the results of this diploma thesis together, OPN can be regarded as a flexible 
polypeptide chain housing local structural and functional interaction motifs separated by 
flexible linker regions. This modular architecture and intrinsic flexibility may be a 
necessary prerequisite for osteopontin’s biological functionality as it allows for 
substantial structural plasticity necessary to accommodate various protein binding 
partners recruited to the cellular surface. 
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7 Materials and Methods  
7.1 Microorganisms 
Organism Strain 
Escherichia (E.) coli DH5 α 
 BL21(DE3) 
7.2 Media 
LB 
20 g LB-Broth 
dissolve in 1l H2O. 
autoclave at 121°C 
store at 4°C 
LB selective media 
add 1 ml of ampicillin (100 mg/ml) and/or chloramphenicol (25 mg/ml) 
and/or kanamycin (25 mg/ml) and/or tetracycline (5 mg/ml) to 1l LB 
prepare fresh 
LB selective agar 
500 ml LB 
7.5 g agar agar 
autoclave at 121°C for 15 min, cool to 55°C,  
add 500 µl of appropriate antibiotics, pour into plates 
store at 4°C 
M9 media 
6 g Na2HPO4x2H2O 
3 g KH2PO4 
0.5 g NaCl 
1 g NH4Cl 
dissolve in 1 l H2O, autoclave at 121°C for 15 min 
add: 
20 ml of 20% glucose 
2 ml of 1 M MgSO4 
10 ml trace elements 
0.2 ml 1 M CaCl2  
M9 media 
for 15N-labelling of proteins 
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see M9 media 
use 15NH4Cl instead of NH4Cl 
M9 media 
for 15N, 13C-labelling of proteins 
see M9 media  
use 15NH4Cl instead of NH4Cl 
use 2 to 4 g 13C-Glucose instead of Glucose (add after autoclaving) 
NZCYM medium 
21.98 g NZCYM 
add H2O to a final volume of 1 l 
autoclave at 121°C for 15 min. 
store at 4°C 
TY 2x 
16 g tryptone 
10 g yeast extract 
5 g NaCl 
add H2O to a final volume of 1 l 
autoclave at 121°C for 15 min. 
store at 4°C 
7.2 Buffers & Solutions 
Seperation Gel 
33% (w/v) acrylamide 
0.9% (w/v) bisacrylamide 
33g acrylamide 
0.9 g bisacrylamide (N,N’-methylene bisacrylamide) 
add H2O to a final volume of 100 ml 
sterilize by filtration (0.2 µm) 
store light-protected at 4°C 
Stacking Gel 
20% (w/v) acrylamide 
1% (w/v) bisacrylamide 
20 g acrylamide 
1 g bisacrylamide (N,N’-methylene bisacrylamide) 
add H2O to a final volume of 100 ml 
sterilize by filtration (0.2 µm) 
store light-protected at 4°C 
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Ammoniumperoxodisulfate (APS) 
10% (w/v) 
1 g ammoniumperoxodisulfate 
add H2O to a final volume of 10 ml 
store at -20°C 
Ampicillin 
100 mg/ml (≅0.27 M) 
1 g ampicillin 
add H2O to a final volume of 10 ml 
sterilize by filtration (0.2 µm) 
store at -20°C 
CaCl2 
1M 
14.7g CaCl2×2H2O 
add H2O to a final volume of 100 ml  
autoclave at 121°C for 15 min 
Chloramphenicol 
25 mg/ml 
add EtOH to a final volume of 10 ml 
store at -20°C 
Coomassie staining solution 
0.5%  (w/v) Coomassie 
50% (v/v) EtOH 
10% (v/v) HOAc 
2.5 g Coomassie Brilliant Blue R-250 
250 ml EtOH (98%) 
50 ml HOAc (99%) 
add H2O to a final volume of 500 ml 
store light protected 
Destaining solution 
30% (v/v) EtOH 
10% (v/v) HOAc 
300 ml EtOH (98%) 
100 ml HOAc. (99%) 
add H2O to a final volume of 1 l 
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Dithiothreitol (DTT) 
1 M 
1.54 g dithiothreitol 
add H2O to a final volume of 10 ml 
sterilize by filtration (0.2 µm) 
store at -20°C 
DNA sample buffer (5x) 
20 mM EDTA 
30 % (w/v) Glycerine 
0.5 % (w/v) SDS 
0.1 % (w/v) Bromphenol blue 
100 µl EDTA 1 M (pH 8.0) 
5 mg bromphenol blue 
1.7 ml glycerine 
125 µl SDS 20 % 
add H2O to a final volume of 5 ml 
store at 4°C 
dNTP Mix 
2 mM dATP 
2 mM dCTP 
2 mM dGTP 
2 mM dTTP 
10 µl dATP 100 mM 
10 µl dCTP 100 mM 
10 µl dGTP 100 mM 
10 µl dTTP 100 mM 
add H2O to a final volume of 500 µl 
aliquote and store at -20°C 
HCl  
1 M 
100 ml HClconc (32 %, ρ=1.16)  
add H2O to a final volume of 1 l 
IPTG  
1 M 
2.4 g IPTG (238.25 g/mol) 
add H2O to a final volume of 10 ml  
sterilize by filtration (0.2 µm) 
store at -20°C 
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Kanamycin 
25 mg/ml 
250 mg Kanamycin monosulfate 
add H2O to a final volume of 10 ml 
sterilize by filtration (0.2 µm) 
store at -20°C 
Laemmli buffer 
25 mM Tris 
190 mM Glycine 
0.1 % SDS 
6 g tris base 
28.75 g glycine  
2 g SDS  
add H2O to a final volume of 2 l 
MgCl2  
1 M 
20.33 g MgCl2×6H2O  
add H2O to a final volume of 100 ml 
autoclave at 121°C for 15 min 
NaCl  
1 M 
58.44 g NaCl  
add H2O to a final volume of 1 l 
autoclave at 121°C for 15 min 
 
NaOH 
1 M 
40 g NaOH 
add H2O to a final volume of 500 ml 
NaP buffer 
100 mM sodium phosphate pH 6.5 
adjust pH by mixing  
100 mM NaH2PO4·H2O 150 mM NaCl  
100 mM Na2HPO4·2H2O 150 mM NaCl  
to a final volume of 1 l 
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PBS buffer 
140 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
10 mM 
8.18 g NaCl 
0.2 g KCl 
1.78 g Na2HPO4 
0.24 g KH2PO4 
add H2O to a final volume of 1 l 
autoclave at 121°C for 15 min 
PBS buffer (high salt) 
1 M NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
10 mM 
58.44 g NaCl 
0.2 g KCl 
1.78 g Na2HPO4 
0.24 g KH2PO4 
add H2O to a final volume of 1 l 
autoclave at 121°C for 15 min 
Protease inhibitor solution 
2x Protein sample buffer 
120 mM Tris×HCl, pH 6.8 
6 % (w/v) SDS 
20 % (v/v) Glycerine 
0.01 % (w/v) Bromphenol blue 
10 % (v/v) β-Mercaptoethanol 
1.2 ml Tris×HCl 1 M (pH 6.8) 
3 ml SDS 20 % 
2 ml glycerine 
1 mg Bromphenol blue 
add H2O to a final volume of 9 ml  
store in 900µl aliquots at -20°C 
thaw only once 
add 100 µl of β-mercaptoethanol to 900 µl of buffer  
store at 4°C 
SDS 20% 
20% SDS (w/v) 
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20 g SDS 
add H2O to a final volume of 100 ml 
Stop Mix (5x) 
20 mM EDTA 
30 % Glycerine 
0.5 % SDS 
0.1 % bromphenol blue 
0.1 ml 1 M EDTA (pH 8.0) 
1.7 ml glycerine 
0.125 ml 20 % SDS 
2 ml 0.5% bromphenol blue 
add H2O to a final volume of 5 ml 
TBE buffer (10×) 
pH 8.3 
0.89 M Tris 
0.89 M Boric acid  
0.02 M EDTA 
108 g tris base 
55 g H3BO3  
7.44 g EDTA Na2·2H2O  
add H2O to a final volume of 1 l  
autoclave at 121°C for 15 min 
Tetracycline 
5 mg/ml 
50 mg tetracycline 
add H2O to a final volume of 10 ml 
sterilize by filtration (0.2 µm) 
store at -20°C 
7.3 DNA Work 
7.3.1 Starter cultures for plasmid preparations 
Inoculate 20 ml of LB medium supplemented with the appropriate 
antibiotics with a single colony from a transformation plate using a sterile 
pipette tip. Alternatively, use 1 µl of a glycerol stock for inoculation. 
Incubate at 37°C and 225 rpm to an OD600 of approximately 1. 
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7.3.2 Preparation of plasmid DNA from bacteria 
Plasmid DNA from bacteria was obtained using Plasmid Mini or Midi Kits 
(Qiagen) according to the manufacturer’s instructions. 
7.3.3 Preparation of competent bacteria  
• Prepare an overnight culture of the respective E. coli strain; inoculate 
NZCYM medium supplemented with the appropriate antibiotics with 
cells from the bacterial stock solution. 
• Inoculate 100 ml of 2x TY medium with 1 ml of the overnight culture. 
Grow the cells at 37 °C and 225 rpm until the optical density at 600 nm 
(OD600) reaches 0.5 to 0.6. 
• Pour the culture into ice-cold 50 ml conical tubes and chill on ice for 10 
min. 
• Centrifuge at 4 °C for 10 min at 4000 x g. Discard the supernatant and 
resuspend the cells in 100 ml ice-cold TFB I solution. Incubate on ice 
for 10 min. 
• Centrifuge as above and suspend the pellet in 4 ml of ice-cold TFB II 
solution. 
• Immediately prepare 100 µl aliquots in pre-chilled 2 ml tubes and store 
them at –80 °C. 
• Test the transformation efficiency by transforming 10 ng of pUC19 
plasmid Dna according to the heat-shock protocol. The efficiency 
should be about 1x106 to 1x107 pfu per µg of DNA. 
7.3.4 Transformation of chemically competent E.coli 
• 100µl of chemically competent E.coli strains DH5 α or BL21(DE3) were 
thawn on ice and mixed with 1-2µl of plasmid (5-10 ng/µl). 
• Following incubation on ice for 30 minutes, cells were kept at 42°C for 
1.5 minutes and then put on ice for 2 minutes. 
• After addition of 1ml of LB medium, cells were incubated at 37° under 
constant shaking for 1 hour. 
• Cells were concentrated by short centrifugation at 13000 rpm and the 
supernatant was discarded, leaving approximately 100µl. The cell 
pellet was resuspended and plated on an agar plate containing the 
appropriate antibiotics 
• Cells were incubated overnight at 37°C.  
7.3.5 DNA Gel-Electrophoresis  
Standard agarose gels for DNA analysis were prepared with 1% agarose 
in 1x TBE buffer. For fragments less than 300bp in length, the amount of 
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agarose was increased to 2%. The agarose gels were run at 40-60 V for 1 
hr. 
7.3.6 DNA Gel Extraction  
The bands containing the DNA fragments of interest were cut out of the 
gel and DNA was eluted with the QIAEXII Gel Extraction Kit (Qiagen) 
according to the manufacturer's protocols. 
7.3.7 Cloning of DNA fragments 
Digestion of DNA with restriction endonucleases 
• Digest DNA in a total volume of 10 µl per µg of plasmid. 
• Add DNA template, about 0.1 µg/µl. 
• Add 1/10 of 10x reaction buffer. 
• Adjust the total reaction volume with H2O, minus the volume of 
restriction enzyme. 
• Add 1 to 2 units of restriction enzyme(s) per µg of DNA template; the 
volume of the enzyme added must not exceed more than 10% of the 
total volume, as the glycerin within the enzyme buffer may inhibit 
restriction. 
• Incubate at the recommended temperature for 2 hrs up to o/n. 
• If necessary terminate the reaction by incubation of the solution at the 
inactivation temperature for 10 to 20 min or by adding 1/4 of the total 
volume of 5x DNA sample buffer. 
• Store at 4°C or directly load onto a gel. 
• If the DNA has to be cleaved with two restriction enzymes or modified 
with other enzymes e.g. alkaline phosphatase or blunt ending 
enzymes, the reactions can be carried out simultaneously if both 
enzymes are active in the same buffer. Alternatively, the enzyme with 
the buffer of lower ionic strength should be used first. The appropriate 
amount of salt and the second enzyme can be added subsequently. 
Another way is to precipitate DNA after the first digestion and then 
perform the second one. 
Ligation of DNA fragments 
• In an Eppendorf tube mix: 
Vector DNA 100 ng 1 µl 
DNA insert 100 ng 3 µl 
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10x T4 DNA Ligase buffer  1 µl 
T4 DNA Ligase  1 µl 
H2O to 10 µl 4µl 
  10 µl 
• incubate at 22 °C for 1.5 hrs. 
• inactivate DNA Ligase at 65 °C for 10 min. 
7.3.8 Quantification of nucleic acids 
• Prepare 100 µl dilutions of DNA in H2O in concentrations of about 5 to 
50 µg/ml. 
• Measure the absorbance at 260 and 280 nm in a UV 
Spectrophotometer. 
• The following assessments can be used for quantification: 
DNA: A260 = 1 at a concentration of 50 µg/ml 
RNA: A260 = 1 at a concentration of 40 µg/ml 
• A ratio of A260/A280 between 1.6 and 2.0 indicates pure DNA or RNA 
without significant protein contamination. 
7.3.9 Polymerase Chain Reaction (PCR) 
Site-directed mutagenesis using cycle PCR 
This protocol is useful to introduce point mutations, replace amino acids, 
and to delete or insert single or multiple adjacent amino acids. It is based 
on the QuikChange II Site-Directed Mutagenesis Kit (Stratagene). 
• Prepare two mutagenic primers that contain the desired mutation and 
anneal to the same sequence on opposite strands of the plasmids. 
• Mutation should be located in the center of the primer sequence, 
flanked by 10 to 15 correct bases on each side. 
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• In a PCR tube mix: 
DNA template 50 ng 2 µl 
oligonucleotide primer #1 100 ng 5 µl 
oligonucleotide primer #2 100 ng 5 µl 
dNTPmix  1 µl 
10x PCR buffer  5 µl 
H2O to 50 µl 31µl 
PfuUltra HF DNA polymerase 2.5 U/µl 1 µl 
  50 µl 
• PCR program: 
denaturation 95 °C 00:00:30 
denaturation 95 °C 00:00:30 
annealing 55 °C 00:01:00 
 
15x 
elongation 68 °C 1 min 
final elongation 68 °C 00:10:00 
hold 4 °C ∞ 
• Add 1 µl of DpnI (10U/ µl) to the amplification reaction and incubate at 
37 °C for 1 hour. DpnI digests the parental supercoiled dsDNA. 
• Transform 1 µl of the digested PCR product into appropriate cells and 
plate on agar plates containing the appropriate antibiotics. 
7.4 Protein Work 
7.4.1 Starter cultures for recombinant protein expression 
Inoculate 20 ml of LB media and the appropriate antibiotics with one 
colony from a transformation plate. 
Incubate at 37 °C and 180 rpm until OD600 reaches ~ 1.0. 
7.4.2 Expression of recombinant proteins 
• Add 10ml of the starter culture to the expression medium containing 
the appropriate antibiotics. 
• Incubate at 37 °C and 225 rpm until OD600 reaches ~ 0.5 (depending 
on the protein to be expressed). 
• Control 1: Pipet 1 ml of the culture into an 1.5 ml tube, centrifuge at 
4000 rpm for 5 min, remove the supernatant and resuspend the pellet 
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in 200 µl of 1x PBS Buffer. Mix with 2x protein sample buffer and store 
at –20°C. 
• Induce protein expression by adding IPTG to a final concentration of 1 
mM. Incubate at 30 °C over night. 
• Control 2: Measure OD600 of the culture. Pipet 1 ml of the culture into a 
1.5 ml tube and centrifuge at 4000 rpm for 5 min. Remove the 
supernatant and suspend the pellet in 200 µl 1x PBS Buffer and lyse 
the cells, e.g. by sonication. Centrifuge at 18000 rpm for 10 min, take a 
sample from the supernatant and mix with 2x protein sample buffer. 
Remove the remainder of the supernatant carefully and resuspend the 
pellet in the same amount of 1x PBS buffer as before. Take a sample 
and mix with 2x protein sample buffer. Store the samples at –20 °C. 
• For harvesting the cells centrifuge the remainder of the culture for 15 
min at 4000 rpm and 4 °C. Remove the supernatant and dissolve the 
pellet in 20 ml of ice-cold 1x PBS buffer per liter of bacterial culture. 
The optimal buffer conditions depend on the properties of the protein of 
interest and have to be optimized for every purification. E.g. use 
TrisxHCl buffer for acidic proteins (purified by anion exchange 
chromatography), or a sodium phosphate buffer for basic proteins 
(purified by cation exchange chromatography). Lysis buffers can also 
contain various amounts of salt (10 to 500 mM), reductants as 0.1% 
(w/v) β-mercaptoethanol or 0.5 to 10 mM DTT, and metal ions if the 
protein is a metal binding protein. 
• Freeze the bacterial suspension in liquid nitrogen and store at –20 °C 
over night or –80 °C for long term storage. 
• Check the expression of the recombinant protein using SDS-PAGE. 
Load 10 to 20 µl of the control samples and compare the amount of 
insoluble and soluble protein fraction. 
7.4.3 Preparation of lysates for protein purification 
• Thaw an aliquot of the bacterial suspension on ice or in a room 
tempered water bath. 
• Sonicate the lysate on ice.This fragmentizes the bacterial DNA, which 
makes the lysate rather viscous. 
• Centrifuge the lysate at 4 °C and 18000 rpm for 15 min. This should 
result in a compact pellet and a clear supernatant. 
• If not previously done, analyze aliquots of the supernatant and the 
pellet equivalent to 50 µl of bacterial culture on a SDS Page for the 
insoluble and soluble protein fraction. 
7.4.4 Precipitation of proteins using ammonium sulfate 
Analytical method 
• For a test precipitation prepare four 200 µl aliquots of lysate containing 
the protein of interest. 
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• Add an appropriate amount of solid ammonium sulfate (using a 
reference table) to the aliquots to adjust to 30%, 40%, 50%, and 60% 
of ammonium sulfate saturation. Mix and cool on ice for 30 min. 
• Centrifuge at 4 °C and 10000 rpm for 30 min. Transfer the 
supernatants to fresh tubes and supplement to a volume of 500 µl with 
lysis buffer. Dissolve the pellets in 500 µl of lysis buffer. 
• Analyze 5 to 10 µl of these solutions corresponding to 100 to 200 µl of 
bacterial culture using SDS-PAGE. To remove the ammonium sulfate 
disturbing electrophoresis precipitate the proteins with trichloric acid as 
described. 
• Determine the ammonium sulfate concentrations where most of the 
protein of interest remains in the supernatant and where most of the 
protein is precipitated. If it is necessary test further concentrations. 
Fractionated preparative precipitation 
• Cool the lysate containing the protein of interest on ice. Add an 
appropriate amount of solid ammonium sulfate to adjust the 
concentration where most of the desired protein remains in the 
supernatant as determined in the analytical experiment. Cool on ice for 
30 min. 
• Centrifuge at 4 °C and 13000 rpm for 15 min. 
• Transfer the supernatant to a fresh tube and again add an appropriate 
amount of ammonium sulfate to adjust to the concentration where most 
of the desired protein precipitates. Cool on ice for 30 min. 
• Centrifuge at 4 °C and 13000 rpm for 15 min. 
• Remove the supernatant and dissolve the protein pellet in a buffer 
suitable for the next purification step. 
7.4.5 Concentration of protein samples  
Concentration with ammonium sulfate  
Precipitation of proteins under native conditions is a fast and mild method, 
suitable not only for purification but also for concentration, e.g. after Iysis 
or after chromatographic purification where proteins are sometimes eluted 
in large volumes.  
• Test the ammonium concentration where the protein of interest 
precipitates quantitatively as described.  
• Dissolve the pellet in a buffer suitable for the next purification step or 
analyses. If the ammonium sulfate remaining in the pellet disturbs the 
subsequent purification step, remove it by means of size exclusion 
chromatography using a HiPrepDesalting column (amersham 
pharmacia biotech). 
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Concentration using membrane filters  
Centriprep or Centricon filters (Amicon) are suitable to generate highly 
concentrated protein samples, e.g. to obtain protein samples of high 
concentration for NMR analysis under native conditions. 
• Transfer the protein solution to a centriprep (up to 15 ml volume) or a 
centricon (up to 2 ml volume) with a cut off value smaller than the 
molecular weight of the protein.  
• Centrifuge at 4000 rpm and 4°C, the buffer will pass the filter while the 
protein will be retained. 
7.4.6 Chromatographic Methods 
The Fast Performance Liquid Chromatography (FPLC) System 
Protein purification was performed using the FPLC system Äktaexplorer 
from amersham pharmacia biotech. Chromatographic methods used were 
ion exchange and size exclusion chromatography. All FPLC purification 
steps were performed at room temperature. 
Size exclusion chromatography for sample desalting 
HiPrep Desalting (amersham pharmacia biotech) is a prepacked column 
for group separation of high (MW > 5000) from low molecular weight 
substances (MW < 1000), e.g. to separate proteins from salt. The bed 
volume of the column is 53 ml, the matrix of the column is Sephadex G-25 
Fine, cross-linked dextran. 
• Choose a buffer system to ensure that the sample is fully soluble. For 
substances carrying charged groups a buffer containing up to 150 mM 
salt (e.g. NaCl) should be used to prevent possible ionic interactions 
with the matrix. Degas the running buffer using a water jet pump and 
filtrate through a ZapCapS (Schleicher&Schuell) bottle top filter (0.2 
µm). 
• Flush the pumps, the valves and the sample applicator of the FPLC 
system with the buffer solutions. 
• Equilibrate the HiPrep Desalting column with at least 5 CV of running 
buffer prior to use. 
• Dissolve the protein of interest in the running buffer or dialyse to this 
buffer. Centrifuge at 4°C and 13000 rpm for 10 min or more or filtrate 
the sample through a filter ring (0.2µm). 
• Load the protein solution onto the column by either using a syringe or 
the sample pump, depending on the sample volume. 
• Elute the column with 5 CV of buffer. 
• Collect fractions of the flow through and the eluate and analyse the 
samples on an SDS-PAGE. 
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• After the separation, flush the FPLC system and wash the column with 
5 CV of water and a minimum of 5 CV of 20% ethanol to prevent 
microbial growth. 
Anion exchange chromatography (Resource Q 6ml) 
Resource Q is a pre-packed column from pharmacia biotech. The matrix is 
composed of monodisperse polystyrene/divinyl benzene beads with 
quaternary ammonium as anion exchanger. It is suitable for purification of 
acidic proteins (pI< 7). The pH of the buffer should be at least 1 pH unit 
above the pI of the protein of interest so that it is negatively charged and 
will bind to the matrix. Anionic detergents should be avoided as they bind 
to quaternary ammonium. The practical protein loading range is up to 150 
mg, whereas the sample volume is of minor importance. 
• Choose a buffer system that is not bound by the exchanger (e.g.: 
Tris×HCl) and prepare two buffer solutions, one with low ionic strength 
(e.g. 10 mM NaCl) and one with high ionic strength (e.g. 0.5 to 1 M 
NaCl). 
• Degas the buffer solutions using a water jet pump and filtrate through a 
ZapCapS bottle top filter (0.2 µm). 
• Flush the pumps, the valves and the sample applicator of the FPLC 
system with the buffer solutions. 
• Equilibrate the column with at least 2 CV of start buffer (low ionic 
strength buffer). 
• Run 2 CV of elution buffer (high ionic strength buffer) through the 
column. 
• Re-equilibrate the column with 5 CV of start buffer. 
• Centrifuge the bacterial lysate at 4°C and 18000 rpm for at least 10 
min to remove insoluble particles. 
• Load the supernatant onto the column using the sample pump.  
• Wash with 5 CV of start buffer. 
• Elute the protein via gradient elution by mixing start and elution buffer 
over e.g. 20 CV lower flow rates and more shallow gradients improve 
resolution. 
• Collect fractions of the flow through and the eluate and analyse the 
samples by SDS-PAGE. 
• After the purification, flush the FPLC system, wash the column with 5-
10 CV of H2O and eventually with ~ 5 CV of 20% ethanol for storage. 
From time to time clean the column with 5 CV 1 M NaCl, 5 CV 1 M 
NaOH, 5 CV 1 M HCl and 5 CV 1 M NaCl, before washing with H2O 
and storing in 20% ethanol. 
Size exclusion chromatography using HiLoad Superdex columns 
HiLoad 16/60 Superdex 75 prep grade is a prepacked column from 
amersham pharmacia biotech. The matrix is produced by covalent 
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bonding of dextran to highly cross-linked agarose. The separation range of 
this column lies in the molecular weight range between 3x103 to 7x104, the 
bed volume is approximately 120 ml. Proteins applied to this column are 
separated according to their size. Large proteins elute first, while small 
proteins can enter the pores of the matrix are thus retarded. This polishing 
step is mostly used as a last step in protein purification to achieve final 
high-level purity. 
• Choose a buffer system that is suitable for the analyses following the 
purification (e.g. sodium or potassium phosphate at appropriate pH). 
Degas the buffer solutions using a water jet pump and filtrate through a 
ZapCapS bottle top filter (0.2 µm). 
• Equilibrate the column with at least 2 CV of running buffer until the 
base line is stable. 
• Flush the pumps, the valves and the sample applicator of the FPLC 
system with the buffer solutions. 
• Dissolve the protein sample in 1 to 2 % of the bed volume (1 to 1.5 ml) 
of running buffer or concentrate to this volume. 
• Centrifuge the protein sample at 4 °C and 18000 rpm for at least 10 
min. 
• Load the protein solution onto the column using a syringe. 
• Elute the column with 1 bed volume of running buffer. 
• Collect fractions of the flow through and the eluate and analyse the 
samples on an SDS-PAGE. 
If the resolution is low, decrease the flow rate or the sample volume or 
amount. Proteins with polar residues on their surface may interact with the 
matrix and are poorly eluted. In this case use buffers with higher ionic 
strength, containing e.g. 150 mM NaCl. Alternatively, gel filtration can be 
performed under denaturing conditions with buffers containing up to 8 M 
urea or up to 6 M guanidinium hydrochloride. 
• After the purification, flush the FPLC system and wash the column with 
a minimum of 3 CV of water and eventually with 4 CV of 20% of 
ethanol. 
 
7.4.7 Quantification of protein 
Coomassie Blue protein assay (Bradford assay) 
• The absorbance maximum of the dye in an acidic solution shifts from 
465 to 595 nm after adding protein due to stabilization of the anionic 
form of the dye by both hydrophobic and ionic interactions. The dye 
principally reacts with arginine residues and to a lesser extent with 
histidine, lysine, tyrosine, and phenylalanine residues. 
• Place 20 µl of the samples I n a 1.5 ml tube. 
• Add 1 ml of Bradford reagent. 
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• Immediately measure the absorbance at 595 nm in polystyrene 
cuvettes. 
• For calibration prepare several dilutions of BSA with protein 
concentrations between 10 and 1000 µg/ml. Treat them in the same 
way as the samples. 
UV spectrometry: absorbance at 280 nm 
Quantitative study of protein-protein and protein-DNA interactions in 
solution requires accurate determination of protein concentration. In 
contrast to the Bradford assay, measurement of the absorbance at 280 
nm results in a quite accurate determination of the protein concentration. If 
the extinction coefficient has not yet been determined experimentally, it is 
possible to calculate the molar extinction coefficient simply from 
knowledge of the amino acid composition.3 Following amino acid residues 
contribute to the extinction coefficient of a protein: Trp (5690 M 1cm 1), Tyr 
(1280 M 1cm 1), Cys (120 M 1cm 1). 
• Search for Trp, Tyr, and Cys residues in the amino acid sequence of 
the protein. Multiply the numbers of these amino acid residues in the 
protein with their contributions to the extinction coefficient of the 
protein. 
• Measure the absorbance of the denatured protein in 6 M 
guanidiumhydrochloride at 280 nm. Choose the concentration of the 
protein so that the absorbance is about 0.5. 
• Calculate the concentration of the protein according to the Lambert-
Beer law: A = ε.c.d, with A being the measured absorbance, ε the 
molar extinction coefficient of the protein, c the concentration of 
protein, and d the path length. 
 
7.4.8 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) of 
proteins 
SDS-PAGE is used for investigation of protein samples in terms of 
contained proteins. Gels containing sodium dodecyl sulfate (SDS) provide 
dissociating conditions, where proteins are separated strictly according to 
polypeptide size. A discontinuous buffer system is used.5, 6 Polyacrylamide 
(PAA) concentration is 15% for all gels, the molecular weight marker 
(Dalton Mark VII-L Standard Mixture, Sigma Aldrich) range is from 14 to 
66 kDa showing bands at 14.2, 20.1, 24.0, 29.0, 36.0, 45.0, and 66.0 kDa. 
Gels are cast using the Mini-PROTEAN 3 Multi-Casting Chamber 
(BIORAD). 
 12 resolving gels 12 stacking gels 
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Tris (pH 9.0) 
Tris (pH 6.8) 
40% PAA (37.5 : 1) 
40% PAA (19 : 1) 
8 ml 
- 
24 ml 
- 
- 
3.5 m 
- 
3.5 m 
H2O 32ml 21ml 
 
20% SDS 
TEMED 
APS 
Degas 
320 µl 
20 µl 
200 µ 
 
70 µl 
35 µl 
140 µl 
• Put the gel into a running cell filled with Laemmli buffer. 
• Load the sample onto the gel. 
• Run the gel at 200 V for 40 min. 
• Incubate the gel in Coomassie staining solution for at least 30 min. 
• Destain the gel in destaining solution until the gel is colourless again, 
except the protein bands. 
• Take a picture of the gel with a Gel Doc System (Sony). 
7.4.9 Circular dichroism spectroscopy of proteins 
Circular dichroism (CD) is defined as the difference in absorption of left 
and right handed circular-polarized light ΔA = AL – AR by chromophores in 
an asymmetrical environment, resulting in elliptically polarized light. CD 
spectroscopy can be used to get information about the structure of 
macromolecules (including the secondary structure of proteins and the 
handedness of DNA). The most commonly used unit in CD spectroscopy 
of proteins is the mean residue ellipticity [kdeg cm² dmol-1], which is 
obtained by normalization with sample concentration, path length of the 
cell and with the number of residues. The mean residue ellipticity is 
measured as a function of wavelength.  
For gaining information about the secondary structure of proteins, CD 
spectra need to be recorded from about 260 nm to ~ 180 nm (far UV). At 
these wavelengths the amide groups of the peptide backbone interact with 
the entering circularly-polarized light. Spectra can be analyzed for different 
secondary structural types: alpha helix, parallel and antiparallel beta 
sheet, random coil, etc. shows typical CD spectra of different secondary 
structural elements.  
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Experimental conditions: 
Protein concentrations were determined by photometry at 280 nm. 
Samples containing 0,5 mM protein dissolved in a sodium phosphate 
buffer (100 mM NaH2PO4/Na2HPO4, 150 mM NaCl, adjusted to pH 6.5) 
were analysed with an “Applied Photosystems Π*-180” spectropolarimeter 
using quartz cells of 1 mm path-length. Spectra were processed by 
subtracting buffer spectra measured under the same conditions.  
Wavelength spectra were obtained at 20°C recorded at 0.5 nm intervals 
from 180 to 260 nm. Using the base spectra of 33 reference proteins, 
quantitative determination of secondary structure elements of the protein 
in question was achieved. 
Temperature scans were performed from 20 to 60°C and the ellipticity at 
218 nm was recorded.  
 
7.5 Specific Protocoll: Osteopontin Expression and Purification 
Bacteria of the E. Coli strain BL21(DE3) transformed with pET11d-
OPN220 expression vector were grown in 20ml LB until an OD600 of 0.5 
was reached. The culture was then added to 1l M9 media supplemented 
with Ampicilline. The bacteria were grown to an OD600 of 0.5 when 
recombinant protein synthesis was induced with IPTG to a final 
concentration of 1mM. The bacteria were grown overnight at 30°C and are 
Fig. 1. Typical CD spectra of 
different secondary structural 
elements (far UV). Spectrum 
α-helix (red); β-sheet (blue); 
random coil (black). The 
ordinate shows the difference 
in absorption of left and right 
handed circular-polarized light 
ΔA = AL – AR as a function of 
the wavelength in nm. 
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ready to harvest on the next day having reached an OD600 of 1.5-2. The 
cells were collected by centrifugation at 4000rpm for 20min and 
resuspended in 20ml of PBS-Buffer supplemented with 1ml Protease 
Inhibitor Cocktail (Sigma). Bacteria were lysed using a sonicator (15min) 
and the cell lysate was cleared by centrifugation at 18000rpm for 20min. 
The supernatant containing the soluble protein fraction was adjusted to a 
(NH4)2SO4 concentration of 40% and cleared by centrifugation 
(18000rpm/20min). The soluble fraction was again adjusted to 50% 
(NH4)2SO4. After another round of centrifugation the precipitate containing 
most of the OPN220 protein was resuspended in 10ml PBS buffer and 
purified form residual (NH4)2SO4 with a desalting column. The fraction 
containing protein were pooled and loaded onto a FPLC anion exchange 
column (ResourceQ). Bound protein was eluted by gradient mixing PBS 
buffer with PBS buffer containing 1M NaCl. The fractions containing 
OPN220 were pooled and concentrated to 1ml with an Amicon centrifugal 
filter device. (10kDa NMWL) and then loaded onto a Superdex Hiload 
16/60 gel filtration column (GE Healthcare) equilibrated in NaP Buffer. For 
NMR analysis, protein samples were concentrated to 0.5mM. 
 
This protocol also applies to single cystein mutant OPN220 purification. 
Only 1mM of DTT was added to all buffers to avoid the formation of 
internuclear disulfide bonds. 
 
All purification steps should be executed as quickly as possible since OPN 
is degrading very fast in solution. Storage overnight during the purification 
process should be at -20°C. 
7.6 Protein NMR 
7.6.1 Introduction 
The technique of NMR takes advantage of a specific property of certain 
nuclei, the nuclear spin. The magnetic resonance phenomenon occurs as 
a result of the quantum mechanical property of the spin, where the 
resulting angular momentum confers a magnetic moment on the nucleus. 
Introduction into a static magnetic field leads to a splitting up into different 
energy levels amenable for the magnetic moment. Irradiation with radio-
frequency pulses leads to excitation of these magnetic moments into 
levels of higher energy and generates detectable signals. 
7.6.2 NMR experiments 
All NMR diffusion measurements were performed on a Varian Inova 
spectrometer, operating at 600 MHZ. 
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NMR experiments are used to obtain physical, chemical and structural 
information of a biological macromolecule. These experiments can provide 
detailed information on the topology, dynamics and three-dimensional 
structure of molecules in solution (and the solid state). NMR Experiments 
are built up of distinct building blocks. A short summary of some basic 
building blocks for NMR experiments used in this work and their principles 
is given in the following section. 
NMR building blocks 
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) 
The INEPT7 sequence transfers I spin polarization from a sensitive 
nucleus with a high gyromagnetic ratio, γI (usually protons, 1H) to S spin 
polarization of a less sensitive nucleus with a lower gyromagnetic ratio, γS 
(e.g. nitrogen, 15N) by means of scalar coupling interaction. The 
experiment yields anti-phase S spin magnetization with respect to spin I. 
The INEPT sequence is the most frequently used method for 
heteronuclear magnetization transfer in NMR experiments in solution with 
indirect detection of the heteronucleus and increases the sensitivity of the 
experiment by γH/γN ≈ 10. 
Sensitivity Enhancement (SE) 
Sensitivity enhancement13 employs the Cavanagh-Rance trick14 to convert 
both coherence transfer pathways which can be obtained in the indirect 
dimension into observable magnetization. Instead of alternatively 
acquiring the cosine and the sine-modulated signal in the indirect 
dimension, both types of modulations are observed simultaneously by 
refocusing the unobservable modulation in an additional spin-echo 
sequence. SE can provide sensitivity improvements by factors up to √2 
relative to conventional experiments. However, due to relaxation during 
the extra delays in the experiment and due to radio-frequency 
inhomogenity in the additional pulses, this theoretical sensitivity 
enhancement is usually not obtained in practice. 
Decoupling 
Coupling (scalar and dipolar) between two spins results in peak splitting, 
thus leading to overcrowded spectra with reduced peak intensities. In 
order to circumvent this problem, the coupling partner has to be decoupled 
during the evolution and acquisition period. This is achieved by applying a 
180° pulse in the center of the evolution period and a series of 180° pulses 
during the acquisition of the FID. The observed peak resembles the 
average frequency of the split peaks. 
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Heteronuclear NMR experiments 
2D 1H-15N HSQC 
This experiment allows the correlation of amide protons with their directly 
attached nitrogen. An INEPT pulse sequence transfers proton 
magnetization (Hz) into nitrogen antiphase heteronuclear single-quantum 
coherence (2HzNy). 15N frequency labeling during a t1 evolution period is 
followed by a refocused reverse INEPT transfer, and subsequent 
sensitivity-enhancement generates detectable proton magnetization. The 
magnetization pathway is as follows: 
1HN → 15N (t1) → 1HN (t2) 
2D 15N T1 experiment 
The 15N T1 experiment15 is basically an HSQC experiment with an 
additional variable delay for specific 15N longitudinal relaxation. The signal 
intensities scale with the loss of magnetization due to longitudinal 
relaxation during this delay. Increasing its duration in a series of 
experiments, relaxation decay curves can be used to determine 15N T1 
times. After INEPT transfer and subsequent refocusing, longitudinal 15N 
magnetization is generated. Relaxation of 15N occurs via dipolar coupling 
between 1H and 15N during a variable period. Effects of cross-correlation 
relaxation mechanisms between 1H - 15N dipolar and 15N CSA coupling 
are eliminated through 1H 180° pulses during the relaxation time. At the 
end of this period longitudinal 15N magnetization is transferred back into 
transverse 15N magnetization, and the coherence pathway proceeds as 
described in the HSQC experiment. The magnetization pathway is as 
follows: 
1HN → 15N → 15N (t1) → 1HN (t2) 
2D 15N T2 Experiment 
The 15N T2 experiment15 is basically an HSQC experiment with an 
additional variable delay (cycles) for specific 15N transverse relaxation. 
The signal intensities scale with the loss of magnetization due to 
transverse relaxation during this delay. Increasing its duration in a series 
of experiments, relaxation decay curves can be used to determine 15N T2 
times. After INEPT transfer and subsequent refocusing transverse 15N 
magnetization is generated. Transverse relaxation occurs during the 
application of a Carr-Purcell-Meiboom-Gill (CPMG) spin-echo sequence16, 
17 with successive 180° 15N pulses to refocus transverse magnetization. 
Effects of cross-correlation relaxation mechanisms between 1H-15N dipolar 
and 15N CSA coupling are eliminated through 1H 180° pulses during the 
relaxation time.18 At the end of this period transverse 15N magnetization 
R1 
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proceeds as described in the HSQC experiment. The magnetization 
pathway is as follows: 
1HN → 15N → 15N (t1) → 1HN (t2) 
CPMG relaxation dispersion experiment 
Many biological events occur on the milli- to microsecond timescale. The 
Carr−Purcell−Meiboom−Gill (CPMG) technique method can be used to 
characterize conformational transitions that are involved in such 
processes.  
The CPMG relaxation dispersion experiment applies a variable number of 
refocusing pulses during a fixed time interval. If the rate of application of 
pulses is such that the magnetization is allowed to get out of phase, then 
the exchange process leads to broad lines. In contrast, when pulses are 
applied at a fast rate, the exchange process is quenched and narrower 
peaks are obtained. The dependence of the peak height on the pulsing 
rate is subsequently used to extract exchange information about the 
protein in question. 
 
R2 
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IPAP experiment for measuring one-bond 15N–1HN residual dipolar coupling 
(RDC) 
RDCs arise when molecular systems containing proximate pairs of 
magnetic nuclei are partially ordered in magnetic fields. The underlying 
mechanism is the same as the through-space dipole-dipole coupling that 
dominates solids NMR spectra. For a pair of spin 1/2 nuclei in a magnetic 
field, the distance and angle dependence are shown in the equation 
below, where r is the distance between a specific pair of nuclei, γi,j are the 
gyromagnetic ratios for the nuclei, µ0  is the permittivity of space, h is 
Planck’s constant, and θ  is the angle between the considered internuclear 
vector and the magnetic field. 
 
When all parameters are given in SI units, the resulting Dij is given in 
Hertz. Many measurements of RDCs are made between pairs of bonded 
nuclei, so that r is fixed; RDCs have, thus, been used primarily to provide 
angular information. Because of the identical spin operators, RDCs add to 
scalar couplings (JHNN) to produce splittings of JHNN + DHNN. 
To obtain 15N–1HN couplings, a 15N HSQC without decoupling the proton 
during nitrogen evolution is recorded. The resulting signal splitting leads to 
a doubling of peaks. This might result in a crowded spectrum with signal 
overlap. To circumvent this problem, two separate spectra can be 
acquired. One contains the inphase component of the coupled 
magnetization, on the antiphase component. (IPAP) Both spectra are 
added and subtracted from each other to yield the upfield and the 
downfield component of the doublet. Splittings are measured under 
isotropic (JHNN) and aligned (JHNN + DHNN) conditions to isolate the RDC 
contribution 
PFG NMR Hydrodynamic Radius Measurements 
In the characterization of native proteins in solution, a measurement of the 
molecular dimensions of the system is of considerable importance. PFG 
(Pulsed Field Gradient) NMR methods are designed to measure the 
hydrodynamic radii of proteins. Dioxan was added to the protein solutions 
as an internal standard. PFG NMR diffusion measurements were 
performed with the PG-SLED (pulse gradient stimulated echo longitudinal 
encode-decode) sequence: 
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The lengths of all pulses and delays in this sequence were held constant 
and 50 spectra were acquired with the strength of the diffusion gradient 
varying between 5% and 100% of its maximum value. The lengths of the 
diffusion gradient and the stimulated echo were optimized for each sample 
to give a total decay in the protein signal of between 80% and 90%. 
 
The diffusion gradient time (δ) used was 4.5 ms and the echo time (Δ) was 
100 ms. 50 experiments were recorded with increasing diffusion gradient 
strength. The data were processed using NMRPipe26. The decay of the 
protein aliphatic proton signal was fitted to a single Gaussian using the 
DOSY module of NMRPipe in order to determine the diffusion constant of 
the protein (dprot). The same procedure was applied to the dioxane 
resonance to determine the diffusion constant of dioxane (dref). The 
hydrodynamic radius of the protein (Rhprot) was deduced from: 
 
 
assuming Rhdiox (hydrodynamic radius of dioxane) is 2.12 Å [57]. 
 
Small-angle x-ray scattering.  
The SAXS equipment consisted of a slit-geometry camera with high flux 
and low background (SAXSess, Anton-Paar, Austria) connected to an X-
ray generator (Philips, PW1730/10) operating at 40 kV and 50 mA with a 
sealed-tube Cu anode (λ = 0.154 nm). A CCD camera, from Princeton 
instruments, a division of Roper Scientifics (Trenton, NJ, USA), recorded 
the 2D scattering pattern. The temperature of the capillary in the metallic 
sample holder was controlled by a Peltier element. Measurements were 
carried out at 25oC. The measuring times were 3×10 min for all samples. 
This allowed for the proper subtraction of cosmic rays that appear when 
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using a CCD camera. The images were then integrated into the one-
dimensional scattering function I(q). This one-dimensional scattering curve 
is a function of the magnitude of the scattering vector q = (4p/l)sin(q/2), 
where q is the total scattering angle. All the intensities were transmission-
calibrated by normalizing the attenuated primary intensity at q=0 to unity, 
and were corrected for the background scattering from the capillary and 
the buffer solution. The absolute scale calibration was made using water 
as a secondary standard.  
The obtained SAXS spectra were further analyzed with the indirect Fourier 
transformation method IFT. IFT is a model-free method used for dilute 
particle systems with negligible particle interactions. In dilute solutions 
interparticle interactions can be neglected. The scattering intensity from 
the scattering particles I(q) can be written as the Fourier transformation of 
the so-called pair-distance distribution function (PDDF) p(r) describing the 
geometry of the scattering particles in the real space:  
         
Here, r is the distance between two scattering centers within the particle. 
The p(r) function represents a histogram of the distance inside the 
scattering particle, which means that the function adopts a value of zero at 
a distance r greater than the maximum dimension of the particle. Particle 
size and shape are two important parameters that can be obtained from 
the p(r) function. 
 
 
7.6.3 Identifying secondary structure elements 
The chemical shift 
In magnetic resonance spectroscopy the electrons in the molecules cause 
the local magnetic field to vary on a submolecular distance scale. Thus, 
the magnetic fields experienced by nuclei at two sites in the same 
molecule are different if the electronic environments are different. This 
effect is called the chemical shift. It is very useful as it allows the atomic 
nuclei to send out a variety of molecular information encoded as radio 
waves. It is highly sensitive to many atomic or molecular effects including 
local electron distributions, bond hybridization states, proximity to polar 
groups, nearby aromatic rings and local magnetic anisotropies. All those 
effects may, in turn, be dependent on the atomic composition, the 
molecular geometry or the solvent constitution. The origin of chemical shift 
dispersion is anisotropic diamagnetic susceptibilities of molecular 
fragments in the polypeptide chain: 
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• Backbone chemical shifts are influenced by the backbone dihedral 
angle φ and, although less pronounced, by ψ, as well as by anisotropy 
effects such as those of carbonyl double bonds. 
• Particularly large effects are due to the local ring current fields of 
nearby aromatic systems. Ring current shifts arise because spins 
above or below an aromatic ring plane experience a local field (Bloc) 
that opposes the static magnetic field B0 and therefore experience an 
upfield shift. Conversely, spins located in the ring plane experience a 
downfield shift. 
• Amide chemical shifts are sensitive to hydrogen bonding. In detail, it 
has been shown that backbone amide HN chemical shifts are related to 
the hydrogen bond length and strength, wherein short (i.e. strong) 
bonds lead to downfield shifts and long (i.e. weak) bonds lead to 
upfield shifts.  
Random coil chemical shifts 
Random coil chemical shifts, δrc, represent the chemical shift of individual 
residues within completely flexible, unconstrained peptides. They fall 
roughly halfway between the chemical shift extremes found for residues in 
α-helices and β-strands. Wishart and coworkers presented 1H, 15N and 13C 
random coil chemical shift values of the common amino acids. Hexa-
peptides of the form gly-gly-x-ala-gly-gly were used as model systems, 
where x represents one of the 20 naturally occurring amino acids. This 
study provides a complete and internally consistent set of 1H, 15N, and 
13Cα random coil chemical shift values. 
Secondary chemical shifts 
Since the 1960s there were a number of attempts on understanding the 
conformational and constitutive effects on chemical shifts of amino acids 
in polymer systems. These efforts were made in an attempt to determine 
the three-dimensional structure of proteins through the precise 
understanding of the geometric dependencies of chemical shifts. First 
simple theories concerned the prediction of shift tendencies in α-protons 
upon helix-formation and further attempts were done until the early 1980s. 
In the 1990s a number of structures were already solved using newly 
developed multidimensional NMR methods. This provided a flood of 
structural data, which was amenable to computational analysis. The 
results of these studies revealed a clear structural relationship for all 20 
amino acids for not only α-protons but for amid protons, α-carbon atoms, 
carbonyl atoms and amide nitrogen atoms.  
In general, observed chemical shifts in proteins can be partitioned into the 
sum of two components: the random coil chemical shifts, δrc, and the 
conformation-dependent ‘secondary chemical shifts’, Δδ.  
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        δobs = δrc + Δδ 
Unlike the random coil chemical shift, the secondary chemical shift 
contains the contribution from secondary and tertiary structure. Especially, 
13Cα and 13Cβ chemical shifts were found to be predominantly determined 
by the backbone φ,ψ dihedral angles.  
 
The average deviation from random coil chemical shifts of 13Cα  is 3.09 ± 1.00 ppm for residues 
located in α-helices and –1.48 ± 1.23 ppm for residues in β-strands, representing a significant 
downfield shift for helical residues and an upfield shift for residues located in β-strands. Conversely, 
the average 13Cβ  shift deviates –0.38 ± 0.85 ppm for α-helical and 2.16 ± 1.91 ppm for β-strand 
conformation. 
13CO secondary shifts are more influenced by residue type and by the 
local amino acid sequence and remain well dispersed, even in the 
unfolded state. Their behavior is similar to 13Cα secondary shifts with a 
downfield shift for residues in helical structures and upfield shifts for 
residues in β-strands. The situation for amide 15N is less clear. Nitrogen 
chemical shifts are found to display very broad chemical shift dispersion 
and despite the average shift difference between α-helices and β-strands 
being more than 3 ppm, the overlap between the two conformational 
groups is often larger than 3 ppm. Due to this the 15N nucleus is not 
expected to be as informative as, for example, carbon.  
7.6.4 Relaxation mechanisms and molecular motions 
NMR relaxation studies can provide detailed information pertaining to the 
internal dynamics occurring in proteins. The measurement of 15N or 13C 
relaxation rates is particularly useful to obtain dynamic information since 
the relaxation of these nuclei is governed predominantly by the dipolar 
interaction with directly bound protons and to a much smaller extent by the 
chemical shift anisotropy mechanism. Relaxation in molecules principally 
occurs either according to the longitudinal or spin-lattice relaxation 
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process or according to the transverse or spin-spin relaxation process. 
Both lead to a decay of the magnetization in an excited spin system and 
constitute the phenomenon of free induction decay, where the time 
constant of the particular contribution is the reciprocal of the relaxation 
rate, R. However, the two mechanisms are distinctly different. 
The longitudinal relaxation is an enthalpic process and is mediated by 
energy exchange with the ‘lattice’, i.e. the sum of translational, rotational 
and internal motions of the molecule. In order to enable the transition form 
the excited state to the ground state, the ‘lattice’ must cause a fluctuating 
field, whose frequency corresponds to the transition. The fluctuating field 
itself is determined by the specific dynamic parameters of the protein, 
such as overall rotational correlation time, internal correlation time and 
chemical exchange processes. The time dependent orientation of a N-H 
bond vector in a protein can be described by a correlation function of the 
form 
   C(t) = e-t/τm 
where the correlation time τm represents the time required for the molecule 
to rotate by roughly one radian about any axis, assumed for isotropic 
molecular tumbling (no preferred axis of rotation). Fourier transformation 
of this correlation function results in the spectral density function, J(ω), 
which gives information about the power available from molecular motions 
to bring about relaxation as a function of the molecular tumbling rate. For 
the R1 mechanism, the relaxation maximum is at ωτm ≈ 1, where ω is the 
resonance frequency in radian units for the transition of the investigated 
nucleus. 
 
 
Rate constants R1 and R2 as a function of the overall tumbling correlation time τm. 
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The transverse relaxation is an entropic process and is mediated by 
mutual exchange of spin energies (mutual spin flip), with no net change in 
energy. This mechanism predominantly occurs due to fluctuating magnetic 
fields when ωτm » 1. 
The heteronuclear {1H}-15N-NOE arises due to energy level redistribution 
of dipole-dipole coupled spins upon perturbation of the equilibrium state. 
Double- and zero- quantum transitions lead to a decrease or increase in 
the population difference of a particular spin, and an enhancement or 
decrease of the corresponding NMR signal arises. Thereby, double-
quantum (high frequency) transitions lead to a positive NOE 
enhancement, whereas zero-quantum (low frequency) transitions lead to a 
negative enhancement. Consequently, the NOE is dependent on the 
present fluctuating magnetic fields and thus dependent on the correlation 
time τm. Motional behavior of the N-H bond vector can be observed directly 
by the sign and the magnitude of the {1H}-15N-NOE. Nevertheless, NOE 
enhancement is determined by comparing signal intensities of the 
individual resonances with and without precedent water saturation and 
thus requires nicely separated signals in order to exclude mutual 
interference from overlapping signals. 
15N T1 and T2 relaxation times are determined from 15N T1 and 15N T2 NMR 
experiments. The delay, during which specific longitudinal and transverse 
relaxation occur, respectively, is varied in a series of experiments. The 
signal intensities in each spectrum, I, scale with the loss of magnetization 
during this delay, t, and relaxation curves for each residue are then 
obtained by plotting the signal intensity versus the duration of the delay. 
The following equation is used in a curve fit program to extract T1 and T2: 
  I(t) = A e –t/T1,2 
where the two variables are the scaling factor A and the relaxation time T1 
and T2. The heteronuclear {1H}-15N-NOE is determined as the ratio of the 
crosspeak intensities in two experiments, one with and one without 
presaturation of the amide proton resonances. 
  NOE = Isat/Inosat 
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